Gauge of Risk

One company says it will soon be offering a DNA-based suicide risk test, Technology Review reports.

Sundance Diagnostics plans to offer its saliva-based test, which is based on research out of the Max Planck Institute of Psychiatry, to doctors beginning next month for patients taking anti-depressants like Prozac or Zoloft. People just beginning anti-depressant treatment are sometimes at increased risk of suicide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Yoshiki Sasai Dies

High Hopes

All Along the Genome

In This Case…

California Testing

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.